{"id": "1346804079788363777", "creation": 1609938089.0, "user_id": "262605583", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "quoted": "1345731168591863810", "text": "In this post, @mathewspgeorge analyses the tenability of the #passingoff claim made in a suit recently filed by against #SerumInstituteofIndia for use of the name '#Covishield' for its #Covid19 #vaccine. \n\n#trademarks #trademarklaw #iplaw #indianiplaw #intellectualproperty https://t.co/2nZrEjrqTr", "first_save": 1634559108.199414, "hashtags": ["#PASSINGOFF", "#SERUMINSTITUTEOFINDIA", "#COVISHIELD", "#COVID19", "#VACCINE", "#TRADEMARKS", "#TRADEMARKLAW", "#IPLAW", "#INDIANIPLAW", "#INTELLECTUALPROPERTY"]}